These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 32189106)

  • 1. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
    Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
    Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.
    Takagi H; Sasaki S; Suzuki H; Toyota M; Maruyama R; Nojima M; Yamamoto H; Omata M; Tokino T; Imai K; Shinomura Y
    J Gastroenterol; 2008; 43(5):378-89. PubMed ID: 18592156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q; Chen L; Shan X; Shan X; Tang J; Zhou F; Chen Q; Quan H; Nie D; Zhang W; Huang AL; Tang N
    Int J Cancer; 2014 Aug; 135(3):635-46. PubMed ID: 24374650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
    Shih YL; Hsieh CB; Lai HC; Yan MD; Hsieh TY; Chao YC; Lin YW
    Int J Cancer; 2007 Sep; 121(5):1028-35. PubMed ID: 17443492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SFRP1 inhibited the epithelial ovarian cancer through inhibiting Wnt/β-catenin signaling.
    Zhang H; Sun D; Qiu J; Yao L
    Acta Biochim Pol; 2019 Nov; 66(4):393-400. PubMed ID: 31770484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
    Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
    Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
    Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative Effects of Epigenetic Modifier Drugs Through E-cadherin Up-regulation in Liver Cancer Cell Lines.
    Uribe D; Cardona A; Esposti DD; Cros MP; Cuenin C; Herceg Z; Camargo M; Cortés-Mancera FM
    Ann Hepatol; 2018; 17(3):444-460. PubMed ID: 29735783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
    Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
    Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoblastomas exhibit marked
    Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
    Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.